Drug Shortage Report for MED-DUTASTERIDE
Report ID | 161670 |
Drug Identification Number | 02416298 |
Brand name | MED-DUTASTERIDE |
Common or Proper name | Dutasteride 0.5 mg |
Company Name | GENERIC MEDICAL PARTNERS INC |
Market Status | MARKETED |
Active Ingredient(s) | DUTASTERIDE |
Strength(s) | 0.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 30 Capsule pack |
ATC code | G04CB |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-06-01 |
Actual start date | 2022-06-01 |
Estimated end date | 2022-09-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-06-02 |
Company comments | For contracted business, an Alternate Supplier has been appointed to supply an equivalent product during the shortage. Auro-Dutasteride DIN 02469308 is available from Auro Pharma, 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1500 DON MILLS ROAD, SUITE 711 TORONTO, ONTARIO CANADA M3B 3K4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-06-02 | English | Compare |
v5 | 2022-06-01 | French | Compare |
v4 | 2022-06-01 | French | Compare |
v3 | 2022-06-01 | English | Compare |
v2 | 2022-06-01 | French | Compare |
v1 | 2022-06-01 | English | Compare |
Showing 1 to 6 of 6